Accumulating evidence have shown that compared with individuals with renin-dependent aldosteronism, those with RIA face a heightened risk of cardiovascular disease (4, 12, 13), and a higher prevalence of chronic kidney disease (5) and metabolic dysfunction-associated steatotic liver disease (6). This evidence concerns the gene REN and chronic kidney disease.